Squarepoint
BIOA

Squarepoint’s BioAge Labs BIOA Stock Holding History

Squarepoint’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$971K Buy
55,520
+4,247
+8% +$81.8K ﹤0.01% 2803
2025
Q4 		$678K Buy
+51,273
New +$454K ﹤0.01% 2948
2025
Q1 		– Sell
-12,263
Closed -$71K – 5578
2024
Q4 		$71K Sell
12,263
-24,051
-66% -$415K ﹤0.01% 4775
2024
Q3 		$755K Buy
+36,314
New +$728K ﹤0.01% 2817

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Squarepoint's BIOA Position: Q1 2026 in Review

Squarepoint increased its BioAge Labs (BIOA) stake by 8.3% in Q1 2026, buying an estimated $81.8K and bringing the position to 55,520 shares worth $971K. The position accounts for ﹤0.01% of the portfolio, ranked #2803.

Squarepoint first reported a position in BIOA in Q3 2024 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Squarepoint held 55,520 shares of BioAge Labs worth $971K as of Q1 2026.
  • Squarepoint bought 4,247 BioAge Labs shares in Q1 2026, an estimated $81.8K.
  • BioAge Labs made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2803 holding.
  • Squarepoint first reported a position in BioAge Labs in Q3 2024 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.